Wang T - Search Results

1

In vitro optimization of liposomal nanocarriers prepared from breast tumor cell specific phage fusion protein.

Wang T, Kulkarni N, Bedi D, D'Souza GG, Papahadjopoulos-Sternberg B, Petrenko VA, Torchilin VP. Wang T, et al. J Drug Target. 2011 Sep;19(8):597-605. doi: 10.3109/1061186X.2010.550920. Epub 2011 Jan 29. J Drug Target. 2011. PMID: 21275826

2

Surface modification of pharmaceutical nanocarriers with ascorbate residues improves their tumor-cell association and killing and the cytotoxic action of encapsulated paclitaxel in vitro.

D'Souza GG, Wang T, Rockwell K, Torchilin VP. D'Souza GG, et al. Among authors: wang t. Pharm Res. 2008 Nov;25(11):2567-72. doi: 10.1007/s11095-008-9674-4. Epub 2008 Jul 11. Pharm Res. 2008. PMID: 18618230

3

Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein.

Wang T, Yang S, Petrenko VA, Torchilin VP. Wang T, et al. Mol Pharm. 2010 Aug 2;7(4):1149-58. doi: 10.1021/mp1000229. Mol Pharm. 2010. PMID: 20438086 Free PMC article.

4

Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity.

Wang T, Petrenko VA, Torchilin VP. Wang T, et al. Mol Pharm. 2010 Aug 2;7(4):1007-14. doi: 10.1021/mp1001125. Mol Pharm. 2010. PMID: 20518562 Free PMC article.

5

Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein.

Wang T, D'Souza GG, Bedi D, Fagbohun OA, Potturi LP, Papahadjopoulos-Sternberg B, Petrenko VA, Torchilin VP. Wang T, et al. Nanomedicine (Lond). 2010 Jun;5(4):563-74. doi: 10.2217/nnm.10.30. Nanomedicine (Lond). 2010. PMID: 20528452 Free PMC article.

6

On the mechanism of targeting of phage fusion protein-modified nanocarriers: only the binding peptide sequence matters.

Wang T, Kulkarni N, D'Souza GG, Petrenko VA, Torchilin VP. Wang T, et al. Mol Pharm. 2011 Oct 3;8(5):1720-8. doi: 10.1021/mp200080h. Epub 2011 Jul 29. Mol Pharm. 2011. PMID: 21675738 Free PMC article.

7

Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein.

Wang T, Hartner WC, Gillespie JW, Praveen KP, Yang S, Mei LA, Petrenko VA, Torchilin VP. Wang T, et al. Nanomedicine. 2014 Feb;10(2):421-30. doi: 10.1016/j.nano.2013.08.009. Epub 2013 Sep 9. Nanomedicine. 2014. PMID: 24028893 Free PMC article.

8

Paclitaxel-loaded PEG-PE-based micellar nanopreparations targeted with tumor-specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumors.

Wang T, Yang S, Mei LA, Parmar CK, Gillespie JW, Praveen KP, Petrenko VA, Torchilin VP. Wang T, et al. Mol Cancer Ther. 2014 Dec;13(12):2864-75. doi: 10.1158/1535-7163.MCT-14-0052. Epub 2014 Sep 19. Mol Cancer Ther. 2014. PMID: 25239936 Free PMC article.

9

Optimization of Landscape Phage Fusion Protein-Modified Polymeric PEG-PE Micelles for Improved Breast Cancer Cell Targeting.

Wang T, Petrenko VA, Torchilin VP. Wang T, et al. J Nanomed Nanotechnol. 2012;Suppl 4:008. doi: 10.4172/2157-7439.S4-008. Epub 2012 Apr 20. J Nanomed Nanotechnol. 2012. PMID: 26451274 Free PMC article.

10

Phage-derived protein-mediated targeted chemotherapy of pancreatic cancer.

Wang T, Narayanaswamy R, Ren H, Gillespie JW, Petrenko VA, Torchilin VP. Wang T, et al. J Drug Target. 2018 Jun-Jul;26(5-6):505-515. doi: 10.1080/1061186X.2017.1405424. Epub 2017 Dec 1. J Drug Target. 2018. PMID: 29132246 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52,790 results

Search Page

Filters